{"id":54580,"date":"2023-03-07T15:03:06","date_gmt":"2023-03-07T14:03:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/"},"modified":"2023-03-07T15:03:06","modified_gmt":"2023-03-07T14:03:06","slug":"omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/","title":{"rendered":"Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023"},"content":{"rendered":"
\n

SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its fourth quarter and year-end financial results for the period ended December 31, 2022, on Monday, March 13, 2023, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results as well as recent developments and highlights.\n<\/p>\n

<\/a><\/p>\n

\nConference Call Details<\/b>\n<\/p>\n

\nTo access the live conference call via phone, participants must register at this link<\/a> to receive a unique PIN. Once registered, you will have two options: (1) Dial in to the conference line provided at the registration site using the PIN provided to you, or (2) choose the \u201cCall Me\u201d option, which will instantly dial the phone number you provide. Should you lose your PIN or registration confirmation email, simply re-register to receive a new PIN.\n<\/p>\n

\nThe live or subsequently archived webcast of the event can be accessed at this link<\/a>.\n<\/p>\n

\nAbout Omeros Corporation<\/b>\n<\/p>\n

\nOmeros is an innovative biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. Omeros\u2019 lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application pending before FDA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). Narsoplimab is also in multiple late-stage clinical development programs focused on other complement-mediated disorders, including IgA nephropathy, COVID-19, and atypical hemolytic uremic syndrome. Omeros\u2019 long-acting MASP-2 inhibitor OMS1029 is currently in a Phase 1 clinical trial. OMS906, Omeros\u2019 inhibitor of MASP-3, the key activator of the alternative pathway of complement, is advancing in clinical programs for paroxysmal nocturnal hemoglobinuria (PNH), complement 3 (C3) glomerulopathy and one or more related indications. For more information about Omeros and its programs, visit www.omeros.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJennifer Cook Williams
\n
Cook Williams Communications, Inc.
\n
Investor and Media Relations
\n
IR@omeros.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its fourth quarter and year-end financial results for the period ended December 31, 2022, on Monday, March 13, 2023, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54580","6":"format-standard","7":"category-industry"},"yoast_head":"\nOmeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its fourth quarter and year-end financial results for the period ended December 31, 2022, on Monday, March 13, 2023, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-07T14:03:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230307005584\/en\/606373\/21\/Omeros_Logo_RGB_with_R.2014.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023\",\"datePublished\":\"2023-03-07T14:03:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/\"},\"wordCount\":336,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005584\\\/en\\\/606373\\\/21\\\/Omeros_Logo_RGB_with_R.2014.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/\",\"name\":\"Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005584\\\/en\\\/606373\\\/21\\\/Omeros_Logo_RGB_with_R.2014.jpg\",\"datePublished\":\"2023-03-07T14:03:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005584\\\/en\\\/606373\\\/21\\\/Omeros_Logo_RGB_with_R.2014.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005584\\\/en\\\/606373\\\/21\\\/Omeros_Logo_RGB_with_R.2014.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/","og_locale":"en_US","og_type":"article","og_title":"Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023 - Pharma Trend","og_description":"SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its fourth quarter and year-end financial results for the period ended December 31, 2022, on Monday, March 13, 2023, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-07T14:03:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230307005584\/en\/606373\/21\/Omeros_Logo_RGB_with_R.2014.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023","datePublished":"2023-03-07T14:03:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/"},"wordCount":336,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230307005584\/en\/606373\/21\/Omeros_Logo_RGB_with_R.2014.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/","url":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/","name":"Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230307005584\/en\/606373\/21\/Omeros_Logo_RGB_with_R.2014.jpg","datePublished":"2023-03-07T14:03:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230307005584\/en\/606373\/21\/Omeros_Logo_RGB_with_R.2014.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230307005584\/en\/606373\/21\/Omeros_Logo_RGB_with_R.2014.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/omeros-corporation-to-announce-fourth-quarter-and-year-end-financial-results-on-march-13-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54580"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54580\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}